On Friday, September 4, Air India announced that it has terminated the services of the pilot-in-command of the Phuket-Delhi flight. The airline confirmed that the pilot tested positive for drug use, which prompted his immediate removal from duty. The termination was effective as of the date of the announcement, and the pilot was relieved of all flight responsibilities pending further investigation. The decision was communicated to the pilot and his union representatives, and the airline has initiated an internal review of its crew screening procedures.
The announcement came hours after the AAIB, the probe agency that examined the Phuket-Delhi flight incident, issued its preliminary report. In that report, the AAIB noted that the pilot's drug use was a serious concern. The report highlighted the need for immediate action to address the safety issue. The agency's findings were made public on the same day as the airline's termination, indicating a coordinated response to the safety breach. The preliminary report also recommended that the airline review its crew health monitoring protocols and urged the aviation regulator to consider additional oversight measures for airlines operating similar routes.
ALSO READ | Apple’s First Foldable iPhone Duo Set for Tonight’s Launch with Leaked Color Lineup and Pricing
In the aviation industry, pilots are subject to random drug and alcohol testing as part of mandatory safety protocols. A positive test result typically leads to immediate suspension, and repeated or serious violations can result in termination of employment. Air India's action aligns with these industry standards and reflects the airline's commitment to maintaining high safety levels. Regulatory authorities oversee compliance with these testing requirements, and any breach can trigger investigations and potential revocation of pilot licenses. The incident has also prompted discussions within the airline about enhancing the frequency of drug tests and implementing more comprehensive health checks for flight crew.
The termination of the pilot-in-command has raised questions about the effectiveness of Air India's internal screening processes and the broader implications for crew health monitoring. The AAIB's findings may lead to recommendations for enhanced oversight and more frequent drug testing for pilots. Air India has stated that it will review its safety protocols in light of the incident. The incident could also influence public perception of the airline's safety record and may prompt other carriers to reevaluate their own drug testing policies.
